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ABSTRACT 
Research on medicinal plants has attracted a lot of attention globally in past few years. A wide variety of 
active phytochemicals, including the flavonoids, terpenoids, lignans, sulphides, polyphenolics, coumarins, 
saponins, furyl compounds, alkaloids, polyines, thiophenes, proteins and peptides of plants and herbs have 
been identified for its medicinal and antiviral properties. Some volatile essential oils of commonly used 
culinary herbs, spices and herbal teas have also exhibited a high level of antiviral activity. However, given 
the few classes of compounds investigated, most of the pharmacopoeia of compounds in medicinal plants 
with antiviral activity is still not known. Several of these phytochemicals have complementary and 
overlapping mechanisms of action, including antiviral effects by either inhibiting the formation of viral DNA 
or RNA or inhibiting the activity of viral reproduction. Assay methods to determine antiviral activity 
include multiple-arm trials, randomized crossover studies, and more compromised designs such as non 
randomized crossovers and pre and post-treatment analysis. Methods are needed to link antiviral efficacy 
or potency and laboratory based research. However, relative success achieved recently using medicinal 
plant/herb extracts of various species that are capable of acting therapeutically in various viral infections 
has raised optimism about the future of phyto-antiviral agents. In this review we illustrates, innumerable 
potentially useful medicinal plants and herbs waiting to be evaluated and exploited for therapeutic 
applications against genetically and functionally diverse viruses families such as Retroviridae, 
Hepadnaviridae, Poxviridae, Reoviridae and Herpesviridae. 
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INTRODUCTION 
Viruses are obligate intracellular parasites, which 
contain little more than bundles of gene strands of either 
RNA or DNA, and may be surrounded by a lipid-containing 
envelope58. Unlike bacterial cells, which are free-living 
entities, viruses utilize the host cell environment to 
propagate new viruses. Viruses that spread easily, kill 
sometimes swiftly, and for which there is no cure or 
vaccine that’s why, in recent years, research on medicinal 
plants has attracted a lot of attention globally39. Like any 
other kind of infection, control of viral infection can be 
affected either as a prophylactic (protective) measure or 
therapeutically, in order to control and alleviate a viral 
infection, which has already been established in the host. 
Unlike bacterial, fungal and parasitic infections, viruses are 
not autonomous organisms and therefore, require living 
cells in which to replicate. Consequently, most of the steps 
in their replication involve normal cellular metabolic 
pathways, and this makes it difficult to design a treatment 
to attack the virion directly, or its replication, without 
accompanying adverse effects on the infected cells58. 
Fortunately, we now know that many viruses have unique 
features in their structure or in their replication cycles, 
and these constitute potential targets. In fact, successful 
antiviral chemotherapy has been achieved against the 
herpes virus with the development of acycloguanosine, 
sold as acyclovir, because it interferes with certain key 
viral enzymes that have distinctive affinities for different 
nucleotide analogues58. Viral enzymes play a key role in 
triggering disease. If viral enzymes could be neutralized, 
viral replication would not take place. The proteolytic 
processing of viral polyprotein precursors by a viral 
protease is essential for maturation of the virus. Designing 
specific inhibitors for each of viral protease is thus a 
desirable objective for researchers now a days. Many 
plants are rich in a wide variety of secondary metabolites 
such as tenins, terpinoids, phenol, alkaloids, and flavonoids 
etc which have been found to be potent antiviral 
properties. At present, plant and herb resources are 
unlimited, as far as the search for useful phyto-chemicals is 
concerned; but these resources are dwindling fast, due to 
the human activity and civilization. We have barely 
scraped the surface in our efforts to exploit the plant world 
for antimicrobials (namely, antiviral, antibacterial and 
antifungal compounds) and immunostimulatory action of 
phytochemicals. Although a significant number of studies 
have used known purified plant chemicals, very few 
screening programmes have been initiated on crude plant 
materials. Virtually all cultures around the globe have 
relied historically, and continue to rely on medicinal plants 
for primary health care. There is currently a worldwide 
upsurge in the use of herbal preparations and the active 
ingredients isolated from medicinal plants in health care. 
Natural products from plants traditionally have provided 
the pharmaceutical industry with one of its most 
important sources of lead compounds and up to 40% of 
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modern drugs are derived from natural sources, using 
either the natural substance or a synthesized version. 
History of Antiviral Medicinal Plants  
Medicinal plant was used for health care, date 
back to the origin of human civilization on the earth. But 
research interests for antiviral agent development was 
started after the Second World War in Europe and in 1952 
the Boots drug company at Nottingham, England, 
examined the action of 288 plants against influenza A virus 
in embryonated eggs. They found that 12 of them 
suppressed virus amplification10. In India, the sale of total 
herbal products is estimated at $ 1 billion and the export of 
herbal crude extract is about $ 80 million, of which 50% is 
contributed by Ayurvedic classical preparations. 
Extraction Methods  
Advice abounds for the amateur herbalist on how 
to prepare healing compounds from plants and herbs. 
Water is almost universally the solvent used to extract 
activity Plants are collected either randomly or by 
following leads supplied by local healers in geographical 
areas where the plants are found. Initial screenings of 
plants for possible antimicrobial activities typically begin 
by using crude aqueous or alcohol extractions and can be 
followed by various organic extraction methods. Since 
nearly all of the identified components from plants active 
against microorganisms are aromatic or saturated organic 
compounds, they are most often obtained through initial 
ethanol or methanol extraction. In fact, many studies avoid 
the use of aqueous fractionation altogether. The 
exceptional water-soluble compounds, such as poly-
saccharides (e.g., starch) and polypeptides, including 
fabatin and various lectins, are commonly more effective 
as inhibitors of pathogen (usually virus) adsorption and 
would not be identified in the screening techniques 
commonly used. Occasionally tannins and terpenoids will 
be found in the aqueous phase, but they are more often 
obtained by treatment with less polar solvents. Any part of 
the plant may contain active components. For instance, the 
roots of ginseng plants contain the active saponins and 
essential oils, while eucalyptus leaves are harvested for 
their essential oils and tannins. Some trees, such as the 
balsam poplar, yield useful substances in their bark, leaves, 
and shoots.  
For alcoholic extractions, plant parts are dried, 
ground to a fine texture, and then soaked in methanol or 
ethanol for extended periods. The slurry is then filtered 
and washed, after which it may be dried under reduced 
pressure and re dissolved in the alcohol to a determined 
concentration. When water is used for extractions, plants 
are generally soaked in distilled water, blotted dry, made 
into slurry through blending, and then strained or filtered. 
The filtrate can be centrifuged (approximately 20,000 3 g, 
for 30 min) multiple times for clarification. Crude products 
can then be used in disc diffusion and broth dilution assays 
to test for antifungal and antibacterial properties and in a 
variety of assays to screen for antiviral activity, as 
described below. Natural-products chemists further purify 
active chemicals from crude extracts by a variety of 
methods. Petalostemumol, a flavanol from purple prairie 
clover, was obtained from the ethanol extract by 
partitioning between ethyl acetate and water, followed by 
partitioning between n-hexane and 10% methanol. The 
methanol fraction was chromatographed and eluted with 
toluene. Terpenoid lactones have been obtained by 
successive extractions of dried bark with hexane, CHCl3, 
and methanol, with activity concentrating in the CHCl3 
fraction. The chemical structures of the purified material 
can then be analyzed. Techniques for further chemical 
analysis include chromatography, bio autography, 
radioimmunoassay, various methods of structure 
identification, and newer tools such as fast atom 
bombardment mass spectrometry, tandem mass 
spectroscopy, high-performance liquid chromatography, 
capillary zone electrophoresis, nuclear magnetic 
resonance spectroscopy, and X-ray cystallography. 
Efficacy Test in Vitro Experiments 
Several methods are available to detect either 
virucidal or inhibitory (antiviral) plant activity. 
Investigators can look for cytopathic effects or plaque 
formation or for transformation or proliferative effects on 
cell lines. Viral replication may be assayed by detection of 
viral products such as DNA, RNA, or polypeptides. The 
method for assaying antiviral substances used in various 
laboratories is not standardized, and therefore the results 
are often not comparable to one another. These authors 
also point out that researchers must distinguish between 
merely toxic effects of agents on host cells and true 
antiviral properties of the plant extracts. It should be 
mentioned here that antiviral assays often screen for 
active substances which prevent adsorption of the 
microorganism to host cells; this activity is overlooked in 
screening procedures for antibacterial and antifungal 
substances.  
Marine Herbs Antiviral Activity 
Natural product research is increasingly turning 
to marine herbs as a source of natural products and is 
currently in preclinical and clinical evaluation. Water 
extracts from Haslea ostrearia and the red marine alga 
Polysiphonia denudata from the Bulgarian Black Sea coast, 
respectively, inhibited the reproduction of HSV in cell 
cultures and affected adsorption and the intracellular 
stages of viral replication as demonstrated by the 
reduction of virus-induced cytopathic effect and viral 
infectivity3,47. In addition, the water-soluble fraction of 
Haslea ostrearia has delayed HIV- 1-induced syncitia 
formation on MT4 cells3. The inhibitory effect of marine 
algae was investigated and found that cyanovirin-N, an 11 
kDa protein from blue green alga irreversibly inactivated 
HIV and also aborted cell to- cell fusion and transmission 
of HIV, due to its high affinity interaction with gp12015. 
The presence of various sulphated polysaccharide groups 
extracted from seaweeds and alga have exhibited many 
biological properties, for example anti-HIV and anti-HSV 
activities and also the inhibition of viral adsorption 
processes15. It is well known that the presence of the 
sulphate group is necessary for antiviral activity, and 
potency increases with the degree of sulphation44. 
Plants with Immunostimulatory Action 
Sambucol, a product isolated from Sambucus nigra 
L., which is effective against various strains of influenza 
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virus and boost immune response by secreting IL-1, IL-6, 
IL-8, TNF-alpha4. The roots extract of medicinal plants 
Heracleum maximum, having antiviral activity along with 
immunostimulatory action as it stimulate IL-6 production 
in the macrophage activation assay.60 Aloe polymannose 
(AP), a mannose biological response modifier (BRM) 
purified from the Aloe barbadensis Miller plant, enhanced 
concentrations of anti-CVB3 antibodies. The data 
conclusively showed that AP can immunopotentiate 
antibody production against capsid protein epitopes of a 
nonenveloped picornavirus and suggests that BRM (AP) 
might be of benefit in enhancing antibody concentrations 
against other enteroviruses and poliovirus vaccine strains. 
More studies are needed to understand viral capsid 
protein function and structural properties in the presence 
the polysaccharide BRM that stimulates the production of 
antibody against nonenveloped viruses. 
The Common Class of Antiviral Compounds Present in 
Medicinal Plants 
The development of viral resistance towards 
antiviral agents enhances the need for new effective 
compounds against viral infections. Medicinal plants have 
a variety of chemical constituents, which have the ability to 
inhibit the replication cycle of various types of DNA or 
RNA viruses. Compounds from natural sources are of 
interest as possible sources to control viral infection. In 
this context various research groups in Asia, Far East, 
Europe and America have given particular attention to 
develop antiviral agents from their native traditional plant 
medicines. The antimicrobial activities of plant oils and 
extracts have been recognized for many years. Recently, 
the oil of Melaleuca alternifolia (tea tree) has gained 
widespread acceptance and it is now the principal 
antimicrobial preservative in a range of pharmaceutical 
cosmetics for external use, such as face and hand washes, 
pimple gels, vaginal creams, foot powders, shampoos, 
conditioners and veterinary skin care products.13 
Terpenoids And Essential Oils 
  The antiviral action of essential oils of Melaleuca 
alternifolia and eucalyptus oil exhibited a high level of 
antiviral activity against HSV-1 and HSV-2 in viral 
suspension tests45. The activities of anti-herpes 
components could be the result of terpinen-4-ol13. Italian 
medicinal plants and food medicines were reviewed40 and 
it was found that essential oil obtained from Santolina 
insularis had direct antiviral effects on both HSV-1 and 
HSV-2 and also inhibited cell-to-cell transmission of both 
herpes types16. Sandalwood oil, the essential oil of 
Santalum album (L.), showed a dose dependent effect 
against HSV-1 but not HSV-2 with no reported 
cytotoxicity2. Recently the antiviral effect of black seed oil 
(BSO) from Nigella sativa was investigated using murine 
cytomegalovirus (MCMV) as a model. Their results show 
that BSO exhibited a striking antiviral effect against MCMV 
infection, which may be mediated by increasing one’s 
innate immunity. Rhus javanica has been shown to exhibit 
anti-HSV-2 activity and potentiate the anti-HSV activity of 
acyclovir in vitro and in vivo35. Moronic acid, a simple 
triterpenoid keto acid with antimicrobial activity21. 
Purified from the herbal extract of Rhus javanica showed 
oral therapeutic efficacy with respect to wild-type HSV- 
(type1 and type 2) infected mice. There is no question 
about the efficacy of triterpenoids, in particular that of 
moronic acid, but it is not clear if this is due to a direct 
antiviral effect or whether this reflects the known healing 
properties of this compound in nonviral mucosal lesions22. 
One might also suggest a role for interferon, which can be 
induced by triterpenoids22. For example, the triterpene 
acids of Geum japonicum such as ursolic acid and maslinic 
acid showed potent inhibitory activity against HIV-1 
protease61. It may at least in part be attributed to 
interference with virus–cell binding, as in the case of 
triterpene glycyrrhizin15 (extracted from the licorice root 
Glycyrrhiza radix). Herpes infections are known to be 
relatively poor responders to interferon22, so the question 
of exactly how triterpenoids work against virus infections 
in vivo remains unanswered. 
Tennins  
Two new hydrolysable tannins, shephagenins A 
and B, isolated along with hippophaenin A and strictinin 
from the leaf extract of Shepherdia argentea, showed a 
remarkable inhibitory activity against HSV-117 and HIV-1 
reverse transcriptase (RT).62 The inhibitory effect of the 
Shepherdia argentea leaf extract on HIV-1 RT was found to 
be caused by tannins, and their activities were stronger 
than that of epigallocatechin gallate as a positive control.62 
Phenolics and Polyphenols 
 Polyphenolic extracts of the leaf of Rubus idaeus 
(raspberry) probably act against most viruses by clumping 
the virus particles together into complexes, which are 
largely noninfective7. viral inactivation in vitro is directly 
attributable to preferential binding of the polyphenol to 
the protein coat of the virus22 whereas, in a systematic 
study of the antiviral activity of a very wide range of 
natural products concluded that polyphenols act 
principally by binding to the virus and/or the protein of 
the host cell membrane and thus arrest absorption of the 
virus56 and may exert their antiviral action43. They 
suggested that the major part of the antiviral activity in 
polyphenols probably derives from their direct 
inactivation of the virus and/or from inhibition of the virus 
binding to the cells. They also noted that although 
polyphenols are known to inhibit viral replication enzymes 
(such as RT for HIV and RNA polymerase for influenza 
virus) and other enzymes (e.g. poly (ADP-ribose) 
glycohydrolase), these effects seem to be rather 
nonspecific. Polyphenols and the proanthocyanidins 
extracted from Hamamelis virginiana bark showed a 
remarkable inhibitory activity against HSV-117 and HIV-1 
reverse transcriptase (RT).62 
Peptides and Polypeptides 
A peptide isolated from the leaves of the 
Argentinean plant Melia azedarach has a peptide was 
evaluated with mice inoculated with HSV-1 strain1. 
Infected animals treated or not with meliacine were 
observed carefully for the development of stromal keratitis 
and the clinical scoring was followed 14 days post 
infection. It was found that meliacine exerted a strong 
antiviral action on HSV-1 induced ocular disease in mice 
with no evidence of toxic effects. There have also been 
reports of the beneficial effects of meliacine in helping to 
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control the Junin hemorrhagic fever virus by inhibiting the 
multiplication of Junin virus in vero cells treated with the 
compound before infection or immediately after virus 
adsorption9. It also inhibited the multiplication of foot and 
mouth disease virus in BHK- 21 cells57. Analysis of early 
events following infection demonstrated that meliacine 
blocks virus penetration by preventing the uncoating step, 
but the addition of meliacine at different times after 
infection indicated that meliacine also interferes with the 
release of infectious particles and inhibits the low-pH-
induced fusion of infected cells9,57. Taken together, these 
results suggest that meliacine affects two events of the 
virus replicative cycle that require membrane fusion: 
uncoating and budding9. Such chemicals might be useful 
therapeutically to block the spread of virus as they prevent 
the initial replication cycles. Previously, it has been shown 
that 1-cinnamoyl-3,11-dihydroxymeliacarpin (CDM), a 
natural compound isolated from leaf extracts of Melia 
azedarach L., inhibits the vesicular stomatitis virus (VSV) 
multiplication cycle when added before or after infection. 
Here, we have established that the lack of VSV protein 
synthesis in CDM pre-treated Vero cells is ascribed to the 
inhibition of an initial step during virus multiplication, 
although indirect immunofluorescence (IFI) studies 
confirmed that the binding and uptake of [35S] methionine 
-labelled VSV was not affected by CDM pre-treatment. 
Instead, our findings revealed that this compound impedes 
the uncoating of VSV nucleocapsids in pre-treated Vero 
cells, since the antiviral action of CDM was partially 
reversed by inducing VSV direct fusion at the plasma 
membrane, and VSV M protein fluorescence was confined 
to the endosomes, even 2 h post-internalization. Further-
more, CDM induced cytoplasmic alkalinization, as shown 
by acridine orange staining, consistent with the inhibition 
of virus uncoating. Although VSV proteins are synthesized 
when CDM is added after infection, IFI studies revealed 
that G protein was absent from the surface of infected cells 
and co-localized with a Golgi marker. Therefore, CDM 
inhibits the transport of G protein to the plasma 
membrane. Taken together, these findings indicate that 
CDM exerts its antiviral action on the endocytic and 
exocytic pathways of VSV by pre or post-treatment, 
respectively. The phenolic compound eugeniin (ellagi-
tannins) extracted from Geum japonicum and Syzygium 
aromaticum demonstrated clearly its anti-HSV activity.27-28 
A detailed analysis was made of viral DNA synthesis, and 
eugeniin was found to inhibit the growth of acyclovir-
phosphonoaceticacid-resistant HSV-1, thymidine kinase-
deficient HSV-1 and wild HSV type 2, and Epstein–Barr 
virus DNA polymerase. One of the major target sites of 
inhibitory action of eugeniin is viral DNA synthesis.27-28, 32 
Polysaccharides 
The HRV genus is perhaps the most common 
cause of gastroenteritis with accompanying diarrhoea in 
infants and remains among the leading cause of early 
childhood death worldwide58. Anti-HRV and anti- HSV-1 
activities of hot water extracts from Stevia rebaudiana and 
Achyrocline flaccida, respectively, have been examined.18, 50 
The extracts inhibited the replication of four serotypes of 
HRV and HSV-1 in vitro by blocking the binding of the 
virus. The inhibitory components of the Stevia rebaudiana 
and Achyrocline flaccida extracts were found to be 
heterogeneous anionic polysaccharides with different 
ionic charges. Polysaccharides extracted from the leaf of 
Rhizophora apiculata (RAP) and the bark of Rhizophora 
mucronata (RMP) were assessed by an in vitro cell culture 
system41-42. Both RAP and RMP protected MT-4 cells from 
HIV-induced cytopathogenicity and blocked the expression 
of HIV p24 antigens (viral capsid protein) preventing the 
virus binding to the cell and the formation of syncytia upon 
co-cultivation of MOLT-4/HIV-1IIIB cells and MOLT-4 cells. 
The mechanisms of the binding of antiviral agents to the 
virion, and the mechanisms of the viral binding to host 
cells in the presence of scleroglucan polysaccharide seems 
to be related to its binding with membrane glycoproteins 
of viral particles which then impedes the complex 
interactions of the virus with the cell plasma membrane33. 
This is particularly important for compounds, which are 
known to affect membranes. Blocking of the viral 
attachment to host cells will prevent the productive 
infection cycle and the viral genome will not be introduced 
into the cell58.  
Flavonoids and Flavonols 
The bioflavonoid comprise a large family of plant 
derived polyphenolic compounds of low molecular weight, 
which exhibit diverse biological activities. The naturally 
occurring benzopyrone derivatives and phenylchromones 
are widely distributed throughout the plant kingdom, as 
components in fruits, vegetables, tea, grains, bark, roots, 
stems and flowers. Up to several hundred milligrams are 
consumed daily in the average Western diet. On balance, a 
considerable body of evidence suggests that plant 
flavonoids may be health promoting, disease-preventing 
dietary compounds34. They are the basis of many 
traditional folk remedies which have many important 
biochemical effects, some of which have been applied in 
human therapy20 and are now being increasingly used as 
prototypes for the development of specific drug therapies6. 
The antiviral activities of bioflavonoids extracted from 
medicinal plants have been evaluated5,53. The black tea 
flavonoid, theaflavin is a well-known antioxidant with free 
radical-scavenging activity and it was able to neutralize 
bovine rotavirus and bovine corona virus infections.12 The 
flavonoid chrysosplenol C is one of a group of compounds 
known to be a potent and specific inhibitor of 
picornaviruses and rhinoviruses, the most frequent 
causative agents of the common cold.46 The Dianella 
longifolia and Pterocaulon sphacelatum were found to 
contain flavonoid chrysosplenol C and anthraquinone 
chrysophanic acid, respectively, which inhibit the 
replication of poliovirus types 2 & 3 in vitro46. Recently, 
new flavonol glycoside the iridoid glycosides and three 
phenylpropanoid glycosides, named luteoside A, luteoside 
B and luteoside C were isolated from Barleria prionitis and 
from the roots of the medicinal plant Markhamia lutea, 
respectively, and shown to have potent in vitro activity 
against RSV25. In another study, five groups of biflavonoids 
(amentoflavone, agathisflavone, robustaflavone, rhus-
flavanone and succedaneflavanone) were isolated from 
medicinal plants of Rhus succedanea and Garcinia 
multiflora, and exhibited various antiviral effects against a 
number of viruses including respiratory viruses (influenza 
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A, influenza B, para influenza type 3, RSV, adenovirus type 
5 and measles) and herpes viruses (HSV-1, HSV-2, HCMV 
and varicella zoster virus, VZV)31. Amentoflavone and 
robustaflavone, demonstrated significant activity against 
anti-HSV-1 and anti-HSV-2 with only moderate anti-HSV- 2 
from rhusflavanone.  
 A significant anti-influenza A and B activity was 
achieved by amentoflavone, robustaflavone and 
agathisflavone. By comparison, rhusflavanone and 
succedaneflavanone were found to produce a selective 
anti-influenza type B only. The inhibitory activities against 
measles and VZV were demonstrated with rhusflavanone 
and succedaneflavanone, respectively. In general, none of 
groups of biflavonoids exhibited anti-HCMV31. Baicalein 
(BA), a flavonoid compound purified from the medicinal 
plant Scutellaria baicalensis Georgi, has been shown to 
possess anti-inflammatory and anti-HIV-1 activities. BA 
may interfere with the interaction of HIV-1 envelope 
proteins with chemokine co-receptors and block HIV-1 
entry of target CD4 cells and BA could be used as a basis 
for developing novel anti-HIV-1 agent30. The fact that the 
RT plays a very important role in controlling the 
replication of HIV makes it one of the most attractive 
targets in the development of anti-AIDS drugs. The 
inhibition of DNA and RNA polymerase by these flavonoids 
was extensively analysed to elucidate the inhibition 
mechanisms36. Once again the degree of inhibition also 
varied depending on the flavonoid. The oligostilbenes 
isolated from the organic extract of the leaves of Hopea 
malibato was also investigated against HIV and found that 
a new oligostilbene dibalanocarpol, together with one 
known oligostilbene balanocarpol exhibited only modest 
HIV-inhibitory activity.  
Coumarins 
Species of the Calophyllum tree produce active 
anti-HIV agents. This has intensified interest in the State’s 
plant resources for scientific research11. One approach has 
been taken to identify novel inhibitors of HIV-1-RT by the 
screening of natural compounds of the Calophyllum tree. 
The most extensive screening effort, carried out by 
researchers was on inophyllum, calanolide A and 
coumarins isolated from the terrestrial plants of 
Calophyllum inophyllum, Cal. lanigerum, Cal. teysmannii 
latex and Cal. cerasiferum, respectively. They possess the 
most interesting natural RT inhibitor14,38,48,52. It was found 
that both inophyllum52 and calanolide A14, a novel subclass 
of nonnucleoside RT inhibitor and merited consideration 
for anti-HIV drug development.  
Lignans 
More than 200 lignans have been identified, and 
they have a widespread distribution in the plant kingdom, 
including many medicinal plants some of which showed 
promising antiviral activities22. Recently, a new class of 
lignans isolated from Larrea tridentates, Rhinacanthus 
nasutus and Kadsura matsudai showed anti-HIV, anti-
influenza and anti-hepatitis potencies, respectively. With 
their important clinical relevance, they do merit further 
investigation.29,30 
 
 
Anthraquinones 
Different kinds of anthraquinones from extracts of 
Rheum officinale, Aloe barbadensis (Aloe vera), Rhamnus 
frangula, Rhamnus purshianus, and Cassia angustifolia 
were found to be quite active against HSV-149. In contrast, 
anthraquinones were found inactive against varicella 
zoster virus, pseudorabies virus, influenza virus, 
adenovirus, poliovirus, semliki forest virus, coxsackievirus, 
measles and rhinovirus49,56. Nonetheless, progress has 
been made with a purified sample of aloe emodin (the 
common aglycones which may exist as anthraquinones), 
prepared from aloin. It inactivated HSV-1, varicella zoster 
virus, pseudorabies virus, influenza virus in vitro, but not 
adenovirus and rhinovirus49. Antiviral activity of a crude 
hot glycerine extract of Aloe vera gel which was grown in 
Bushehr (Southwest of Iran) against HSV-2 replication in 
Vero cell line. The extract showed antiviral activity against 
HSV-2 not only before attachment and entry of virus to the 
Vero cells but also on post attachment stages of virus 
replication. The IC50 before attachment and entry of virus 
to the cells is 428 μg/ml and the CC50 value which is the 
cytotoxicity of the extract for Vero cells is 3238 μg/ml, 
while the calculated selectivity index (SI) is 7.56. Also, IC50 
of extract on post attachment stages of replication is 536 
μg/ml and the SI value for inhibition of the post 
attachment stages of HSV-2 replication is 6.04. Therefore, 
compounds of Aloe vera from Bushehr could be a good 
candidate as a natural source for antiviral drug 
development against HSV-2.24 
Miscellaneous 
Phy. niruri extracts can act therapeutically against 
hepatitis B infections to halt the spread of virus and 
immune complexes and thus allow the restoration of 
normal liver histology and functions22,59. An aqueous 
preparation from Acacia arabica var. indica Benth 
(Mimosaceae) (locally known as “babul”) leaves (BExt) 
was assessed for its in vitro antiviral activity using peste 
des petits ruminants virus (PPRV) as a test model in the 
Vero cell system. Cytopathic effect (CPE) inhibition, virus 
titration, cell ELISA, sandwich-ELISA (s-ELISA), and PCR 
assays were used to determine the antiviral effects (at 
maximum noncytotoxic concentrations 150 and 200 
μg/mL) against PPRV, and in vitro cytotoxicity assays 
established the relative safety concentration of the BExt 
for the cells. BExt inhibited viral infectivity drastically in 
terms of decreased virus titer and antigen load in a dose-
dependent manner either when added to cell monolayers 
pos tinfection or when pre incubated with virus before 
adsorption on the cells. Inhibition of cell-free and cell-
associated PPRV during replication in presence of BExt in 
Vero cells, using a multistep growth curve experiment, 
were assessed by s-ELISA. BExt (200 μg/mL) completely 
inhibited PPRV replication in Vero cells that were infected 
with PPRV at 0.01 multiplicity of infection. Incubation of 
PPRV with BExt (150 and 200 μg/mL) followed by 
infection had a virucidal effect on subsequent progeny 
virus yield by a 3 log10 TCID50 reduction. This indicates 
that active principle( s) of BExt either inactivated the virus 
or inhibited the viral release. Real-time PCR data based on 
nucleoprotein gene showed 196.7- and 770.6-fold 
reduction in the viral load in the presence of BExt 
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concentrations of 150 and 200 μag/mL, respectively, 
indicating the efficacy of BExt in inhibiting PPRV 
multiplication. These data suggest that extracts of A. 
arabica could be a potential natural antiviral agent for 
management of PPR disease and also a possible addition in 
the traditional phyto-antiviral repertoire for viral disease 
control55. Hepatitis C virus (HCV) is emerging as a serious 
worldwide problem. The use of the botanical components 
glycyrrhizin, catechin, silymarin and phytosterols, and the 
antioxidants N-acetylcysteine and vitamin E were 
reviewed for their efficacy in treating chronic hepatitis and 
affecting liver damage37. The potential of medicinal herbs 
Acacia nilotica, Boswellia carterii, Embelia schimperi, Piper 
cubeba, Quercus infectoria, Trachyspermum ammi and 
Syzygium aromaticum extracts were investigated in vitro 
and a significant inhibiting activity against HCV protease 
were reported23. More recently, five patients with chronic 
hepatitis C were treated for 1 year with Iscador Spezial 
(Weieda, Schwabisch, Germany), the brand name of an 
aqueous Viscum album extract. The yields in HCV 
production was reduced about 6–20-fold in two patients 
along with normalization of liver function and improved 
life quality and there were no serious side effects54. The 
potential of phyto-therapy for treatment of HIV positive 
patients was studied and recently in the USA a phase I 
dose-escalating clinical trial of andrographolide extracted 
from Andrographis paniculata was conducted in 13 HIV 
positive patients and five HIV uninfected, healthy 
volunteers8. The planned regimen was 5 mg kg)1 body 
weight for 3 weeks, escalating to 10 mg kg)1 bodyweight 
for 3 weeks, and to 20 mg kg)1 bodyweight for a final 3 
weeks. At the end of the trial there was a significant rise in 
the mean CD4+ lymphocyte level of HIV subjects after 
administration of 10 mg kg)1 andrographolide. There 
were no statistically significant changes in mean plasma 
HIV-1 RNA levels throughout the trial. It was concluded 
that andrographolide may inhibit HIV-induced cell cycle 
disregulation, leading to a rise in CD4+ lymphocyte levels 
in HIV-1 infected individuals. It is well known that HSV is 
an example of a classic latent viral infection58. A double-
blind, placebo-controlled, randomized trial was carried out 
to treat 66 patients with a history of recurrent herpes 
labialis (at least four episodes per year) using a 
standardized balm mint cream, Lomaherpan (Natural 
Medicine Research, Emmenthal, Germany), prepared from 
Melissa officinalis (L.) leaves extract26. The cream was 
smeared on the affected area four times daily over 5 days. 
The tested formulation was found to be effective for the 
treatment of herpes simplex labilalis without any cytotoxic 
side reactions. It remains to be further investigated 
whether the extract of Melissa officinalis (L.) leaves also 
has a therapeutic advantage to treat infections of genital 
mucosa, and HSV-2, which invades the sciatic nerve 
ganglia. 
CONCLUSION 
 Many traditional medicinal plants and herbs were 
reported to have strong antiviral activity as well as 
immune-stimulatory activity. Aqueous and organic 
extractions have in general proved equally fruitful; thus it 
is not feasible at present to assert which method of 
extraction is preferable. In view of the signification 
number of plant extracts that have yielded positive results 
it seems reasonable to conclude that there are probably 
numerous kinds of antiviral agents in these materials. 
Further characterization of the active ingredients will 
reveal useful compounds. Some of these compounds 
belong to a wide range of different structural classes, e.g. 
coumarins, flavonoids, tannins, alkaloids, lignans, terpenes, 
naphtho- and anthraquinones, polysaccharides, proteins 
and peptides. There may also be novel phytochemicals. 
Although large numbers of new compounds have been 
isolated from medicinal plants only some have been 
marketed as pharmaceutical products. Some compounds 
have been or are undergoing various phases of clinical 
trials. The traditional use of some of the medicinal plants 
for the treatment of infectious diseases of viral origin, 
therefore, is justified. Finally, the development of new 
medicinal plant products is vital in controlling the threats 
posed by some pathogenic viruses against which neither 
vaccine (prophylaxis) nor therapeutics are available.  
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